SANTA CLARA, Calif., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Miramar Labs, Inc., (OTCQB:MRLB), a global aesthetic company, announced today that the Company will present at two investor conferences in November 2016. The first presentation will be at the Canaccord Genuity Medical Technologies & Diagnostics Forum in New York, NY.
| Event: | Canaccord Genuity Medical Technologies & Diagnostics Forum | ||
| Date: | Thursday, November 17th, 2016 | ||
| Time: | 3:00 p.m. ET |
The second presentation will be at the 28th Annual Piper Jaffray Healthcare Conference in New York, NY.
| Event: | 28th Annual Piper Jaffray Healthcare Conference | ||
| Date: | Tuesday, November 29th, 2016 | ||
| Time: | 12:10 p.m. ET |
Audio webcasts of the Company’s presentations will be available online at www.miramarlabs.com/investors. Replays of the presentations will be available for 30 days.
Investors who are not attending the conference but would like to schedule a one-on-one meeting with Miramar management may do so by contacting Chris Nardo at The Ruth Group at cnardo@theruthgroup.com.
About Miramar Labs:
Miramar Labs, Inc.® is a global medical device company dedicated to bringing innovative and clinically proven applications to treat unmet needs in the aesthetic marketplace. Supported by rigorous clinical research, Miramar Labs is focused on addressing medical conditions for which there are significant unmet clinical needs. The company’s first priority is the treatment of bothersome underarm sweat, an issue that hundreds of millions of people deal with daily. The miraDry® procedure has an established safety and efficacy profile with over 80,000 patients treated worldwide. Physicians and patients are encouraged to visit www.miramarlabs.com or www.miradry.com for additional information.